Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Needham

Here's How Needham Views Sprout Social's Collaboration With TikTok

On May 26, Sprout Social, Inc (NASDAQ:SPT) announced its content marketing integration with TikTok, which has been in the works. It represents the latest platform integration, with one of the ten most prominent social media networks globally. Needham analyst Scott Berg believes that the integration expands SPT’s strategic reach in the social media marketing…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga

Needham Is 'More Optimistic' on WalkMe's Value Proposition After Q1 Performance - Read Why

Needham analyst Scott Berg maintained WalkMe Ltd (NASDAQ:WKME) with a Buy and lowered the price target from $40 to $20 (132.3% upside) post Q1 FY22 results. Berg attended WalkMe's first Analyst Day, becoming more optimistic about its value proposition and ability to become a more strategic partner with customers. Also Read: Here's How KeyBanc Rates WalkMe Post…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Zoom Beats Estimates, But Could Have Rough Year: What 8 Analysts Have To Say

Quarterly revenue and earnings per share from Zoom Video Communications (NASDAQ: ZM) came in better than anticipated from analysts. Here are the key takeaways from analysts on what’s next for the video technology company.

Benzinga

10 Biggest Price Target Changes For Tuesday

Needham reduced WalkMe Ltd. (NASDAQ: WKME) price target from $40 to $20. WalkMe shares dropped 8.1% to close at $12.20 on Monday.

Benzinga

Here's How Needham Views Block After Its Analyst Day

Mayank Tandon from Needham has reiterated a Buy on Block, Inc (NYSE:SQ) with a price target of $135 (65.9% upside). Last week, Tandon attended SQ's virtual analyst day. Management laid out its view of the company's bright future given the numerous growth drivers in the Seller and Cash App ecosystems, compelling LT unit economics for each…

Benzinga

Government Infrastructure Bills Drive High-Growth Expectations For Fiber-Optics Telecom Clearfield (CLFD)

Telecommunications company Clearfield Inc. (NASDAQ: CLFD) recently reported fiscal second-quarter revenues grew 80 percent and earnings were up 154 percent when compared with the same period last year.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why Needham Is Concerned About Competition Despite Promising Pipeline For This MedTech Stock

Needham believes the most meaningful announcements for Cardiovascular Systems Inc (NASDAQ: CSII) over the last 18 months could be: Partnership with Innova Vascular to develop a portfolio of thrombectomy devices.

Benzinga

7 Walt Disney Analysts React To Q2 Earnings Miss, Subscriber Beat, Ongoing Asia Weakness

Walt Disney Co (NYSE: DIS) shares traded lower by 3.7% on Thursday after the company reported first-quarter earnings and said ongoing COVID-19 disruptions are weighing on its Asia theme park business.

Benzinga

Needham Maintains Buy Rating for GLOBALFOUNDRIES: Here's What You Need To Know

Needham has decided to maintain its Buy rating of GLOBALFOUNDRIES (NASDAQ:GFS) and lower its price target from $87.00 to $70.00. Shares of GLOBALFOUNDRIES are trading down 5.06% over the last 24 hours, at $50.06 per share. A move to $70.00 would account for a 39.83% increase from the current share…

Benzinga

3 Block Analysts React To Q1 Earnings Miss, Cash App Growth, Bitcoin Weakness

Block Inc (NYSE: SQ) reported a first-quarter earnings miss driven by a sharp downturn in Bitcoin (CRYPTO: BTC) revenue.

Benzinga

Fubo Shares Bleed As Analysts Re-rate Stock Post Q1 Results

Analysts remained concerned over fuboTV Inc (NYSE:FUBO), as reflected by their re-rating post Q1 results. Needham analyst Laura Martin maintained FuboTV with a Buy and lowered the price target from $15 to $5 (49% upside). Gross margins of negative (2)% were the lowest FUBO had reported since 2Q20 when it only had 286,000 paid subscribers. The…

Benzinga

Needham Maintains Buy Rating for Selecta Biosciences: Here's What You Need To Know

Needham has decided to maintain its Buy rating of Selecta Biosciences (NASDAQ:SELB) and lower its price target from $7.00 to $6.00. Shares of Selecta Biosciences are trading up 2.84% over the last 24 hours, at $0.83 per share.

Benzinga

'Still A Second-Half Story': Twilio Analysts React To Mixed Q1 Earnings

Twilio Inc (NYSE: TWLO) shares dropped 2.7% on Thursday after the company reported conservative second-quarter guidance.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga

Needham Maintains Buy Rating for Twilio: Here's What You Need To Know

Needham has decided to maintain its Buy rating of Twilio (NYSE:TWLO) and lower its price target from $350.00 to $200.00. Shares of Twilio are trading down 3.58% over the last 24 hours, at $114.24 per share. A move to $200.00 would account for a 75.07% increase from the current share…

Benzinga

10 Biggest Price Target Changes For Thursday

Needham cut Cirrus Logic, Inc. (NASDAQ: CRUS) price target from $110 to $100. Cirrus Logic shares rose 4.5% to close at $82.81 on Wednesday.

Benzinga

Read How Analysts Reacted To Paycom Software's Q1 Results

Analysts reiterated their ratings on Paycom Software, Inc (NYSE:PAYC) post Q1 results. Needham analyst Ryan MacDonald reiterated the Buy rating and $450 price target on Paycom Software following the company's stellar start to FY22, in which revenue and adjusted EBITDA exceeded consensus expectations. PAYC put up a sizeable 1Q22 beat and raise driven by solid sales…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target

Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged.

Benzinga

Lyft Analysts React To Q2 Guidance Miss, Heavy Investments In Lagging Driver Recovery

LYFT Inc (NASDAQ: LYFT) shares plummeted 32% on Wednesday after the company issued second-quarter guidance that came up well short of market expectations.

Benzinga

'Pent-Up Demand Driving Strength': Airbnb Analysts React To Q1 Earnings Beat

Airbnb Inc (NASDAQ: ABNB) shares traded higher by 4.9% on Wednesday after the company reported big first-quarter earnings growth and said it expects a sharp rebound in summer travel in 2022 as pandemic headwinds abate.

Benzinga

Needham Maintains Buy Rating for MagnaChip Semiconductor: Here's What You Need To Know

Needham has decided to maintain its Buy rating of MagnaChip Semiconductor (NYSE:MX) and lower its price target from $29.00 to $25.00. Shares of MagnaChip Semiconductor are trading down 4.83% over the last 24 hours, at $17.35 per share.

Benzinga

Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues

Masimo Corp's (NASDAQ:MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 75,700 in Q1 of 2022. The adjusted operating margin remained unchanged at 22.9%. The company reported…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022

Upgrades

Benzinga

Why Are Accolade Shares Down Over 40% Today

Accolade Inc (NASDAQ:ACCD) shares plunged almost 50% after disappointing Q4 FY22 earnings and FY23 guidance. Q4 FY22 revenue increased 58% Y/Y to $93.8 million, beating the consensus of $91.57 million. The company reported a wider net loss of $(34.56) million compared to $(4.73) million a year ago. EPS loss came at $(0.51)…

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.